Stocklytics Platform
Asset logo for symbol RXST
RxSight
RXST61
$48.93arrow_drop_up2.25%$1.08
Asset logo for symbol RXST
RXST61

$48.93

arrow_drop_up2.25%

Income Statement (RXST)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
EBIT-$8.33M-$9.08M-$10.85M-$13.64M-$11.84M
EBITDA-$7.51M-$7.94M-$9.76M-$12.51M-$10.81M
gross Profit$24.25M$20.68M$17.65M$13.73M$12.01M
NET Income-$6.07M-$9.10M-$9.17M-$12.41M-$13.80M
total Revenue$34.88M$29.51M$28.58M$30.66M$20.81M

Balance Sheet (RXST)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
cash Equivalents-----
net Debt-$13.03M-$30.12M-$6.68M-$6.52M$14.65M
stockholders Equity$275.20M$163.92M$160.36M$161.47M$157.18M
total Assets$305.49M$183.16M$182.55M$181.85M$195.26M
total Debt$11.41M$2.52M$3.01M$3.33M$23.41M
total Liabilities$30.29M$19.23M$22.18M$20.37M$38.07M

Cash Flow (RXST)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
financing Cash Flow$111.55M$7.99M$5.15M-$8.23M$891.00K
free Cash Flow-$5.63M-$11.27M-$11.48M-$8.63M-$9.36M
investing Cash Flow----$4.39M
operating Cash Flow-$4.10M-$9.30M-$9.88M-$7.98M-$7.54M

RxSight (RXST) Financials

RxSight, Inc. (RXST) is a medical technology company that specializes in developing innovative solutions for vision correction. The company's income statement shows a steady increase in total revenue over the past few years, indicating a growing customer base and demand for their products. The gross profit margin for RxSight, Inc. (RXST) is also impressive, suggesting efficient cost management and strong pricing power. Furthermore, the company has consistently generated positive net income from stockholders, demonstrating its ability to generate profits and provide returns to investors.
The balance sheet of RxSight, Inc. (RXST) reflects a healthy financial position, with significant stockholders' equity and total assets. This indicates a strong foundation and ability to support future growth initiatives. The company's total debt is relatively low, indicating a manageable level of financial leverage. Moreover, RxSight, Inc. (RXST) has a favorable mix of cash equivalents and net debt, providing flexibility for investments and strategic initiatives.
In terms of cash flow, RxSight, Inc. (RXST) has consistently generated positive operating cash flow, indicating a steady stream of cash from its core operations. The company's investing cash flow reflects a focus on long-term growth and innovation, as evidenced by investments in research and development and acquisitions. Additionally, RxSight, Inc. (RXST) has managed its financing cash flow effectively, using a combination of debt and equity to fund its operations and growth initiatives.
Overall, RxSight, Inc. (RXST) demonstrates strong financial performance and a solid financial position. With a focus on developing innovative solutions for vision correction and a growing customer base, the company is well-positioned for future success.
add RxSight to watchlist

Keep an eye on RxSight

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media